Sumitomo Mitsui Trust Holdings, Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sumitomo Mitsui Trust Holdings, Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$35,478,066
-12.0%
1,388,574
-1.2%
0.03%
-6.5%
Q2 2023$40,293,450
+18.3%
1,404,932
-1.2%
0.03%
+24.0%
Q1 2023$34,069,160
+38.6%
1,421,325
-1.9%
0.02%
+31.6%
Q4 2022$24,576,058
+13.6%
1,449,060
-0.7%
0.02%
+5.6%
Q3 2022$21,629,000
-4.3%
1,459,415
+1.6%
0.02%
+5.9%
Q2 2022$22,606,000
-40.2%
1,436,194
+2.4%
0.02%
-32.0%
Q1 2022$37,800,000
-24.8%
1,402,078
+3.3%
0.02%
-19.4%
Q4 2021$50,240,000
-22.6%
1,357,472
-0.1%
0.03%
-22.5%
Q3 2021$64,911,000
+57.9%
1,358,532
+11.8%
0.04%
+66.7%
Q2 2021$41,112,000
+215.2%
1,214,901
+284.7%
0.02%
+200.0%
Q1 2021$13,043,000
+123.4%
315,812
+134.6%
0.01%
+100.0%
Q4 2020$5,839,000
+3.8%
134,604
+2.6%
0.00%0.0%
Q3 2020$5,627,000
-17.7%
131,170
-10.4%
0.00%
-20.0%
Q2 2020$6,840,000
+97.3%
146,352
-42.6%
0.01%
+66.7%
Q1 2020$3,466,000
+13.6%
255,066
-9.1%
0.00%
+50.0%
Q4 2019$3,050,000
-0.5%
280,548
-6.0%
0.00%
-33.3%
Q3 2019$3,066,000
+149.9%
298,530
+129.7%
0.00%
+200.0%
Q2 2019$1,227,000129,9740.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders